0000899243-20-021896.txt : 20200810 0000899243-20-021896.hdr.sgml : 20200810 20200810173542 ACCESSION NUMBER: 0000899243-20-021896 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200806 FILED AS OF DATE: 20200810 DATE AS OF CHANGE: 20200810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KURIYEL RALF CENTRAL INDEX KEY: 0001733143 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 201090518 MAIL ADDRESS: STREET 1: 41 SEYON ST STREET 2: BLDG 1, STE. 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-06 0 0000730272 REPLIGEN CORP RGEN 0001733143 KURIYEL RALF C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 Senior VP, R&D Common Stock 2020-08-06 4 M 0 5000 33.87 A 31089 D Common Stock 2020-08-06 4 S 0 5000 153.79 D 26089 D Stock Option (Right to Buy) 33.87 2020-08-06 4 M 0 5000 0.00 D 2028-03-01 Common Stock 5000 5850 D $153.79 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.53 to $154.05, inclusive. The reporting person undertakes to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 6,566 of the shares underlying this option have vested. 4,284 shares shall vest and become exercisable on March 1, 2021. /s/ Jeffrey P. Leduc (Attorney in Fact) 2020-08-10